3
Orphan Designations
0
FDA Approvals
10
Rare Diseases
0
News Articles
| Disease | Drug(s) | Designation | Approved |
|---|---|---|---|
| ALG3-congenital disorder of glycosylation | Recombinant human keratinocyte growth factor | Orphan Designation | - |
| acute graft versus host disease | Interleukin-1 receptor antagonist, human recombinant | Orphan Designation | - |
| autosomal recessive inherited pseudoxanthoma elasticum | Recombinant human keratinocyte growth factor | Orphan Designation | - |
| chronic graft versus host disease | Interleukin-1 receptor antagonist, human recombinant | Orphan Designation | - |
| dermatitis, atopic, 8 | Recombinant human keratinocyte growth factor | Orphan Designation | - |
| graft versus host disease | Interleukin-1 receptor antagonist, human recombinant | Orphan Designation | - |
| juvenile idiopathic arthritis | Interleukin-1 receptor antagonist, human recombinant | Orphan Designation | - |
| myopathy, reducing body, X-linked, childhood-onset | Recombinant human keratinocyte growth factor | Orphan Designation | - |
| reducing body myopathy | Recombinant human keratinocyte growth factor | Orphan Designation | - |
| streptococcus, group A, severity of infection by | Recombinant human keratinocyte growth factor | Orphan Designation | - |